- Home
- DVA
DVA
DaVita Inc.
as 04-18-2025 1:35pm EST
| Founded: | 1994 | Country: | United States |
| Employees: | N/A | City: | DENVER |
| Market Cap: | N/A | IPO Year: | 1995 |
| Target Price: | $159.75 | AVG Volume (30 days): | 855.6K |
| Analyst Decision: | Hold | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 10.73 | EPS Growth: | 44.61 |
| 52 Week Low/High: | $125.64 - $179.60 | Next Earning Date: | 05-01-2025 |
| Revenue: | $12,815,550,000 | Revenue Growth: | 5.56% |
| Revenue Growth (this year): | 5.65% | Revenue Growth (next year): | 3.66% |
Stock Insider Trading Activity of DaVita Inc. (DVA)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| BERKSHIRE HATHAWAY INC | DVA | 10% Owner | Feb 14 '25 | Sell | $155.12 | 750,000 | $116,055,616.32 | 35,142,479 | |
| BERKSHIRE HATHAWAY INC | DVA | 10% Owner | Feb 11 '25 | Sell | $156.01 | 203,091 | $31,684,430.00 | 35,142,479 |
Latest DaVita Inc. News
DVA Breaking Stock News: Dive into DVA Ticker-Specific Updates for Smart Investing
Motley Fool
10 hours ago
3 No-Brainer Warren Buffett Stocks to Buy Right Now
Motley Fool
20 hours ago
Why DaVita Stock Got Rocked This Week
Insider Monkey
a day ago
DaVita Inc. (NYSE:DVA): A Case of Limited Growth Potential
Zacks
2 days ago
DaVita HealthCare (DVA) Stock Declines While Market Improves: Some Information for Investors
Argus Research
4 days ago
DVA: Rating increased to a BUY
Healthcare Dive
4 days ago
DaVita hit by ransomware attack
Investopedia
5 days ago
S&P 500 Gains and Losses Today: Palantir Stock Jumps as NATO Enlists AI Military System
Investopedia
5 days ago
Top Stock Movers Now: Palantir, Apple, DaVita, and More
Compare DVA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DVA DaVita Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.